@article{UBHD-68413200,
  author={Ehren, Rasmus and Fichtner, Alexander and H{\"o}cker, Britta and K{\"a}stner, B{\"a}rbel and Luntz, Steffen P. and Sander, Anja and T{\"o}nshoff, Burkhard},
  title={Initial treatment of steroid-sensitive idiopathic nephrotic syndrome in children with mycophenolate mofetil versus prednisone},
  subtitle={protocol for a randomised, controlled, multicentre trial (INTENT study)},
  year={2018},
  pages={10 S.},
  language={eng},
  issn={2044-6055},
  volume={8(2018},
  note={Gesehen am 29.07.2019},
  journal={BMJ open},
  doi={10.1136/bmjopen-2018-024882},
}
@article{UBHD-67869676,
  author={K{\"a}stner, B{\"a}rbel and Lutz, Nadine and B{\"u}rger, Friederike and Luntz, Steffen P. and Hinderhofer, Katrin and Bendszus, Martin and Hoffmann, Georg F. and Ries, Markus},
  title={Clinical research in vulnerable populations},
  subtitle={variability and focus of institutional review boards’ responses},
  year={2015},
  pages={8 S.},
  language={eng},
  issn={1932-6203},
  volume={10(2015},
  note={Gesehen am 08.09.2015},
  journal={PLOS ONE},
  doi={10.1371/journal.pone.0135997},
  url={http://dx.doi.org/10.1371/journal.pone.0135997},
  library={UB},
}
@article{UBHD-68132506,
  author={Weller, Michael and K{\"a}stner, B{\"a}rbel and Wick, Antje and Platten, Michael and H{\"u}sing, Johannes and Wick, Wolfgang},
  title={MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma},
  subtitle={The DIRECTOR trial},
  year={2015},
  pages={2057-2064},
  language={eng},
  issn={1557-3265},
  volume={21},
  number={9},
  note={Gesehen am 29.06.2017},
  journal={Clinical cancer research},
  doi={10.1158/1078-0432.CCR-14-2737},
}